<p>Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer</p>-Reference-Cited by-同舟云学术

Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer

Published:2020-11 Issue: Volume:Volume 12 Page:475-485
ISSN:1179-1454
Container-title:Journal of Experimental Pharmacology
language:en
Short-container-title:JEP

Author:

Cimino Sarah K,Eng Cathy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Molecular Medicine

Reference75 articles.

1. National Cancer Institute. Cancer stat facts: colorectal cancer SEER data. Available from: https://seer.cancer.gov/statfacts/html/colorect.html. Accessed September 29, 2020.

2. Patterns of metastasis in colon and rectal cancer

3. Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

4. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

5. Axis of evil: molecular mechanisms of cancer metastasis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments;Cancer and Metastasis Reviews;2023-12-19

2. Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells;Oncotarget;2023-06-21

3. Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia;Bioactive Materials;2023-03

4. Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth;Pharmaceuticals;2022-04-24

5. Therapeutic Targets of KRAS in Colorectal Cancer;Cancers;2021-12-11